Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Christina, Kogia"'
Autor:
Antonis, Polymeris, Christina, Kogia, Paraskevi, Kazakou, Stavroula, Psachna, Dimitrios, Lilis, Maria, Drakou, Konstantinos, Michalakis, Dimitrios, Ioannidis
Publikováno v:
Endocrine Regulations. 56:249-253
A 59-year-old woman presented with flushing attacks accompanied by tachycardia and hypotension, which lasted approximately 30 to 60 minutes, underwent 18 years ago a gastrointestinal tumor resection. The histologic examination revealed a poorly diffe
Autor:
Christina Kogia, Dimitrios Ioannidis, Sofia Tseleni-Balafouta, Nicoletta Maounis, Antonis Polymeris, Loukas Kaklamanis, Dimitrios Lilis, Maria Drakou
Publikováno v:
Eur Thyroid J
Introduction: Leukocytosis and particularly neutrophilia are usually caused by acute infection, inflammation, and myeloproliferative neoplasms. However, leukocytosis can also occur in patients with malignancy either due to bone marrow metastases or i
Autor:
Eleni Herolidi, Nektaria Papanikola, Andromahi Vryonidou, Nikolaos Kalogeris, Apostolos Lafkas, Antonis Polymeris, Christina Kogia
Publikováno v:
Endocrine Abstracts.
Publikováno v:
Endocrine Abstracts.
Publikováno v:
Reviews in endocrinemetabolic disorders. 17(3)
The human skin is a well-organized organ bearing different types of cells in a well-structured interference to each other including epidermal and follicular keratinocytes, sebocytes, melanocytes, dermal papilla cells and fibroblasts, endothelial cell
Autor:
Panayiotis A. Theodoropoulos, Elias Castanas, Achille Gravanis, Christos Stournaras, Marilena Kampa, Efstathios N. Stathopoulos, Ploutarchos Anezinis, Christina Kogia, Evangelia A. Papakonstanti, Ioannis Charalampopoulos, Anastassia Hatzoglou
Publikováno v:
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics, American Association for Cancer Research, 2006, 5 (5), pp.1342-51. ⟨10.1158/1535-7163.MCT-05-0527⟩
Molecular Cancer Therapeutics, American Association for Cancer Research, 2006, 5 (5), pp.1342-51. ⟨10.1158/1535-7163.MCT-05-0527⟩
Genomic signaling mechanisms require a relatively long time to get into action and represent the main way through which steroid hormones affect target cells. In addition, steroids may rapidly activate cellular functions by non-genomic signaling mecha
Autor:
Elias Castanas, Ploutarchos Anezinis, K. Darivianaki, Marilena Kampa, Efstathios N. Stathopoulos, Constantina Dambaki, Christina Kogia, Panayiotis A. Theodoropoulos, Michael Nomikos
Publikováno v:
BMC Cancer, Vol 5, Iss 1, p 148 (2005)
BMC Cancer
BMC Cancer
Background Steroid action is mediated, in addition to classical intracellular receptors, by recently identified membrane sites, that generate rapid non-genomic effects. We have recently identified a membrane androgen receptor site on prostate carcino
Autor:
Antoine Bosson-Kouamé, Artemissia-Phoebe Nifli, Elias Castanas, Christos Stournaras, Chantal Castagnino, Joseph Vercauteren, Natalia Papadopoulou, Christina Kogia, Marilena Kampa
Publikováno v:
Experimental cell research. 309(2)
The present work reports a new mode of action of the naturally occurring flavanols catechin and epicatechin and their dimers B2 and B5, in the breast cancer T47D cell line, namely, their interaction with membrane androgen receptors. We show that mono
Autor:
Achille Gravanis, Christina Kogia, Marilena Kampa, Ploutarchos Anezinis, Christos Stournaras, Constantina Dambaki, Anastassia Hatzoglou, Elias Castanas, Efstathios N. Stathopoulos, Evangelia A. Papakonstanti, Ioannis Charalampopoulos, Panayiotis A. Theodoropoulos
Publikováno v:
The Journal of clinical endocrinology and metabolism. 90(2)
Nongenomic androgen actions imply mechanisms different from the classical intracellular androgen receptor (iAR) activation. We have recently reported the identification of a membrane androgen receptor (mAR) on LNCaP human prostate cancer cells, media